# Cost Utility Analysis of Erythropoietin for Anemia Treatment in Hemodialysis Patients

> **NCT01049711** · — · COMPLETED · sponsor: **Mahidol University** · enrollment: 152 (actual)

## Conditions studied

- Chronic Renal Failure

## Interventions

- **DRUG:** erythropoietin

## Key facts

- **NCT ID:** NCT01049711
- **Lead sponsor:** Mahidol University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2010-02
- **Final completion:** 2010-09
- **Target enrollment:** 152 (ACTUAL)
- **Last updated:** 2015-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01049711

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01049711, "Cost Utility Analysis of Erythropoietin for Anemia Treatment in Hemodialysis Patients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01049711. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*